SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-080971
Filing Date
2022-12-19
Accepted
2022-12-19 17:04:34
Documents
1
Period of Report
2022-12-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3910
  Complete submission text file 0001213900-22-080971.txt   5224
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address
Tegge Jonathan (Reporting) CIK: 0001755310 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39685 | Film No.: 221471911